Recursion Pharmaceuticals Inc vs DENTSPLY SIRONA Inc — how do they compare? Recursion Pharmaceuticals Inc trades at $3.37 (market cap $1.81B), while DENTSPLY SIRONA Inc trades at $11.69 (market cap $2.31B). The key difference: DENTSPLY SIRONA Inc is the larger of the two by market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | XRAY | |
|---|---|---|
Market Cap | $1.81B | $2.31B |
Sector | Health | Health |
52-Week High | $6.79 | $14.68 |
52-Week Low | $2.84 | $9.64 |
Enterprise Value | $1.33B | $4.39B |
Dividend Yield | — | 5.04% |
Trailing returns across standard periods
Latest headlines on both assets
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →